4923-61-9Relevant articles and documents
Cytotoxic activity of naphthoquinones with special emphasis on juglone and its 5-O-methyl derivative
Montenegro, Raquel Carvalho,Araújo, Ana Jérsia,Molina, María Teresa,Filho, José Delano Barreto Marinho,Rocha, Danilo Damasceno,Lopéz-Montero, Eulogio,Goulart, Marília O.F.,Bento, E.S.,Alves, Ana Paula Nunes Negreiros,Pessoa, Cláudia,de Moraes, Manoel Odorico,Costa-Lotufo, Letícia Veras
, p. 439 - 448 (2010)
The cytotoxicity of nine naphthoquinones (NQ) was assayed against HL-60 (leukaemia), MDA-MB-435 (melanoma), SF-295 (brain) and HCT-8 (colon), all human cancer cell lines, and peripheral blood mononuclear cells (PBMC), as representatives of normal cells, after 72h of incubation. 5-Methoxy-1,4-naphthoquinone was the most active compound, showing IC50 values in the range of 0.31 (1.7μM) in HL-60 to 0.88μg/mL (4.7μM) in SF-295 and IC50 of 0.69μg/mL (3.7μM) against PBMC. With the introduction of a bromo-substituent in position 2 or 3 of juglone, the IC50 significantly decreased, regardless of the position on the NQ moiety. However, compared with juglone methyl ether, the halogen substitution decreased the activity. To further understand the mechanism underlying the cytotoxicity of 5-methoxy-1,4-naphthoquinone, studies involving DNA fragmentation, cell cycle analysis, phosphatidyl serine externalization, mitochondrial depolarization and activation of caspases 8 and 3/7 were performed in HL-60 cell line, using doxorubicin as a positive control. The results indicate that the cytotoxic 5-methoxy-1,4-naphthoquinone activates caspases 8 and 3/7 and thus induces apoptosis independent of mitochondria.
Carbocyclic frenolicin analogues: Novel anticoccidial agents
Armer, Richard E.,Dutton, Christopher J.,Fenner, Brian R.,Greenwood, Sean D. W.,Hall, Kim T.,Rudge, Andrew J.
, p. 139 - 142 (1998)
Carbocyclic analogues of the antibacterial natural product frenolicin B have been synthesised. These analogues were active against parasitic protozoa of the genus Eimeria and represent a new series of anticoccidial agents. The synthesis of simplified analogues helped to define a possible pharmacophore for frenolicin.
Hannan et al.
, p. 2153,2157 (1979)
2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease
Mezeiova, Eva,Janockova, Jana,Andrys, Rudolf,Soukup, Ondrej,Kobrlova, Tereza,Muckova, Lubica,Pejchal, Jaroslav,Simunkova, Miriama,Handl, Jiri,Micankova, Petra,Capek, Jan,Rousar, Tomas,Hrabinova, Martina,Nepovimova, Eugenie,Marco-Contelles, Jose Luis,Valko, Marian,Korabecny, Jan
supporting information, (2020/12/29)
Alzheimer's disease is a progressive brain disorder with characteristic symptoms and several pathological hallmarks. The concept of “one drug, one target” has not generated any new drugs since 2004. The new era of drug development in the field of AD build
Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues
Chen, Ling,Gao, Jin-Lei,Hao, Ying,Kong, Fan-Rong,Liu, Hong-Dou,Liu, Li-Jun,Liu, Su-You,Luo, Zhi-Yong,Ma, Da-You,Wang, Liu-Liu,Xie, Yuan-Zhu,Zou, Zi-Zheng
, (2020/06/22)
Natural quinones and their analogues have attracted growing attention because of their novel anticancer activities. A series of novel isothiazoloquinoline quinone analogues were synthesized and evaluated for antitumor activities against four different kind of cancer cells. Among them, isothiazoloquinolinoquinones inhibited cancer cells proliferation effectively with IC50 values in the nanomolar range, and isothiazoloquinolinoquinone 13a induced the cell apoptosis. Further exploration of possible mechanism of action indicates that 13a not only activates ROS production through NQO1-directed redox cycling but also inhibits the phosphorylation of STAT3. These findings indicate that 13a has potential use for the development of new skeleton drug candidate as an efficient substrate of NQO1 and STAT3 inhibitor.